Alone, even the most comprehensive omics dataset offers an incomplete picture of human biology. Multiomics, which combines multiple levels of biology, including genomics, transcriptomics, proteomics ...
Adjusted EBITDA -- $1.1 million for the period, compared to an adjusted loss of $1.4 million in the same quarter last year.
The Cancer Biomarkers Market is poised for robust expansion driven by escalating industry demand, accelerated technological ...
Personalized medicine promises to significantly improve patient outcomes, but achieving this requires a deep understanding of human health and disease mechanisms at the molecular level. The advent of ...
The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).
The field of exercise science is rapidly evolving through the integration of omics technologies, giving rise to promising subdisciplines such as enduromics ...
Genomics continues to revolutionize how scientists investigate health, disease, and biological complexity. From automated sample preparation to cutting-edge single-cell sequencing, the field is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback